UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000023009
Receipt No. R000026438
Scientific Title Phase 2b study of combined immunotherapy with dinutuximab, interleukin-2, and G-CSF for high risk neuroblastoma
Date of disclosure of the study information 2016/07/04
Last modified on 2019/07/08 12:56:13

No. Disposal Last modified on Item of update
1 Insert 2016/07/04 16:18:52
2 Update 2016/11/21 20:09:57 Institutions
3 Update 2016/11/21 20:11:15 Recruitment status
4 Update 2016/12/06 15:38:43 Institutions
5 Update 2018/01/04 10:16:56 Recruitment status
6 Update 2018/07/09 17:15:06


7 Update 2019/07/08 12:56:13 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
Institutions


Contact us.